http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
100m 달리기시 최고 속도 구간과 감속 구간의 동작 비교 연구
은선덕,정철수,배성제 한국운동역학회 1996 한국운동역학회지 Vol.6 No.1
본 연구의 목적은 100m 달리기에서 최고 속도 구간과 감속 구간에서의 동작을 비교하여 감속의 원인을 규명하는 데 있다. 두 구간에 대한 주요 운동학적 변인인 신체 중심의 속도와 변위, 보속과 보폭, 상체의 전경각, 관절각, 각속도를 분석하여 다음과 같은 결론은 얻었다. 감속 구간에서의 지면 접촉 기간 동안과 체공 기간 동안의 신체 중심의 수평 속도는 최고 속도 구간에 비해 느린 것으로 나타났다. 보속은 최고 속도 구간에 비해 느린 것으로 나타났고, 지지 시간은 긴 것으로 나타났으며, 체공 시간은 차이가 나타나지 않았다. 보폭은 최고 속도 구간에 비해 짧은 것으로 나타났고, 착지시 신체 중심과 발끝의 수평 거리는 최고 속도 구간에 비해 긴 것으로 나타났다. 또한 상체의 전경각은 착지시에만 차이가 있었으며 최고 속도 구간에 비해 작고, 무릎 관절각은 착지시와 이지시에 있어서 최고 속도 구간에 비해 작았다. 그리고 고관절각은 반대발의 이지시와 착지시, 그리고 최소값에 있어서 최고 속도 구간에 비해 크고, 운동 범위에 있어서는 작은 것으로 나타났다. 또한 무릎 관절 각속도는 최고 속도 구간과의 비교에서 차이가 나타나지 않았다. The study was conducted to make a comparative analysis of running motion and to examine the difference in the deceleration phase(80∼90m) and the Max-speed phase(30∼40m) during the 100-meter Sprint. In this study, data was analyzed with variables including velocity and displacement of center of gravity, stride frequency, stride length, foward angle of upper body, joint angle, angular velocity in the deceleration phase and the max-speed phase. The conclusions of the study were as follows ; 1. Horizontal velocity of the center of gravity in the deceleration phase was found to be slower than that in the max-speed phase in the supporting period and non-supporting period. 2. Stride frequency in the deceleration phase was found to be slower than that in the max-speed phase, and supporting time n the deceleration phase was longer than that in the max-speed phase, also there was no difference between each phase in nonsupporting time. 3. Stride length in the deceleration phase was to be found shorter than that in the max-speed phase. 4. Horizontal distance between the center of gravity and toe in the deceleration phase was to be found longer than that in the max-speed phase. 5. Forward angle of upper body at the moment of touch down in the deceleration phase was found to be smaller than that in the max-speed phase. 6. Knee angle at the moment of touch down and take off in the deceleration phase were found to be smaller than in the max-speed phase. 7. Hip angle at the moment of touch down and take off of the other foot, and minimum hip angle in the deceleration phase were found to be larger than that in the max-speed phase, and range of, motion in the deceleration phase was smaller than that in the max-speed phase. 8. Knee angular velocity at the moment of touch down of the other foot toward flection in the deceleration phase was found to be larger than that in the max-speed phase.
흰쥐 Kupffer 세포에 대한 Propofol의 작용
박세훈,지대림,성언기,김희선,송인환,박희영,김준수,이덕희,박대팔 대한마취과학회 2002 Korean Journal of Anesthesiology Vol.43 No.4
Background: Propofol has an antioxidant capacity and can be used for ischemia-reperfusion injury of the liver. However, the effects of propofol on the Kupffer cells have not been establisked. Methods: Kupffer cells were isolated and cultured from male Sprague-Dawley rats. The effects of propofol on the Kupffer cells were evaluated by a phagocytosis assay, TNF-α gene expression, and superoxide anion release after administering propofol in different concentrations on the cultured Kuprrer cells. Results: The latex bead phagocytosis by the Kupffer cells was suppressed when the Kupffer cells were exposed to propofol irrespective of concentrations. Higher propofol concentrations decreased the loss of Kupffer cells after latex bead phagocytosis. Propofol induced TNF-α mRNA expression in the Kupffer cells, but the mRNA expression level after 50㎍/ml of propofol decreased. The pattern of TNF-α mRNA expression induced by propofol was different to that induced by LPS: TNF-α mRNA was expressed continuously in the propofol-treated cells until 16 hours after exposure to propofol, whereas the level of TNF-α mRNA expression induced by LPS was evident after 2 hours and was not found thereafter. TNF-α production after propofol treatment was not higher than that of the control. Formazan presipitation did not show any qualitative differences between cells untreated or treated with propofol concentrations of 0.5, 5.0, and 50 ㎍/ml. Conclusions: These results showed that propofol might inhibit Kupffer cells. This suggests that propofol and be used for patients with ischemia-reperfusion injury of the liver. (Korean J Anesthesiol 2002; 43: 475~484)
Clinical Outcomes of Late Conversion to Once-Daily Tacrolimus after Liver Transplant
( Deok Gie Kim ),( Yoon Bin Jung ),( Jee Youn Lee ),( Jae Geun Lee ),( Sung Hoon Kim ),( Han Dai Hoon ),( Man Ki Ju ),( Gi Hong Choi ),( Jin Sub Choi ),( Myoung Soo Kim ),( Soon Il Kim ),( Dong Jin Jo 대한간학회 2018 춘·추계 학술대회 (KASL) Vol.2018 No.1
Aims: Since a once-daily tacrolimus (TAC-OD) has been introduced in the field of transplantation, many studies reported advantages of the new drug, such as the better adherence and the less intrapatient variability than the twice-daily tacrolimus (TAC-TD). Recently, promising results were announced regarding better clinical outcomes of the early conversion to TAC-OD in liver transplant patients. In this study, we investigated clinical outcomes of late conversion to TAC-OD more than 6 months after transplantation. Methods: A total 281 patients who received liver transplant patient from January 2012 to January 2017 took TAC-TD from operation. Of them, 38 patients were converted to TAC_OD 6 months after transplantation, while others remained with TAC-TD. We compared graft survival and postoperative complication between two groups, especially with regard to biliary complication known as implication of chronic rejection. Results: Among the patients, 151 were living donor liver transplantation. There was no difference in demographics and operative characteristics between two groups. Biliary stricture occurred later after 6 month after transplantation was 18 (7.4 %) in TAC-TD and 2 (5.3 %) in TAC-OD. The cumulative incidence was not statistically different. However, overall graft survival rate was significantly higher in TAC-OD than that in TAC-TD (P=0.049). Biliary stenosis free survival was also higher without significance (P=0.065). Adverse event of drug was similar between two groups. Conclusions: Late conversion to TAC-OD was safe and feasible. It has advantages of graft survival compared to TAC-TD.
( Deok Woo Lee ),( Ji Hye Yang ),( Sang Min Lee ),( Chong Hyun Won ),( Sung Eun Chang ),( Mi Woo Lee ),( Jee Ho Choi ),( Kee Chan Moon ) 대한피부과학회 2011 Annals of Dermatology Vol.23 No.3
Background: Subcutaneous panniculitis-like T-cell lymphoma (SPTL) is a distinctive skin lymphoma characterized by neoplastic T-cell infiltration of the subcutaneous tissue, mimicking panniculitis. Objective: To describe the clinical and pathologic features of SPTL in Korean patients. Methods: Fourteen SPTL patients evaluated over 15 years were retrospectively reviewed. Results: The mean patient age was 35 years (range: 7~73 years), with male predominance (2.5:1). Most patients presented with either nodules or plaques, occurring most commonly on the trunk, with two patients (14%) having hemophagocytic syndrome. Histopathologically, all patients showed infiltrates of small-to- medium pleomorphic cells mimicking panniculitis, with some also showing rimming, bean-bag cells, and fat necrosis. Most patients were positive for CD3 (14/14), CD8 (12/13), TIA-1 (9/9) and βf1 (5/5), but were negative for CD4 (11/12), CD20 (8/8), CD56 (14/14) and Epstein-Barr virus (8/8). Ten patients (71%) received chemotherapy and 2 (14%) died due to the disease, with an average survival time of 4 months. Survival analysis did not reveal any significant prognostic factors. Conclusion: This is the first series of patients with SPTL in Korea. Due to its indolent clinical course and relatively high survival rate, SPTL should be differentiated from cutaneous γδ T-cell lymphoma.